CD274 and melanoma: Moreover, it was observed that global hypomethylation, not only the PD-L1 promoter methylation status, was positively associated with the expression of PD-L1 in melanoma, indicating that the expression of DNA methyltransferases could lead to PD-L1 expression and immunotherapy resistance [28].